year
111Category: | Pharmaceuticals and Biochemicals |
|
|
CAS NO: | 520-26-3 | ||
EC NO: | 208-288-1 | ||
Molecular Formula: | C28H34O15 | ||
Molecular Weight: | 610.5606 | ||
Specification: | |||
InChI: | InChI=1/C28H34O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-7,10,17,19,21-30,32-37H,8-9H2,1-2H3/t10?,17-,19?,21-,22+,23-,24-,25?,26?,27+,28+/m0/s1 | ||
Synonyms: | Hesperidin;Hesperidine;(S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one;Vitamin P;5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[3,4,5-trihydroxy-6-[(3,4,5 -trihydroxy-6-methyl-oxan-2-yl)oxymethyl]oxan-2-yl]oxy-chroman-4-one;7-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.be ta.-D-glucopyranosyl ]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methox yphenyl)-, (S)-, 4H-1-Benzopyran-4-one, 7-[[6-O- (6-deoxy-.alpha.-L-mannopyranosyl-.bet a.-D-glucopyranosyl] oxy]-2,3-dihydro-5-hydr;Cirantin;Glucopyranoside;hesperetin-7[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)]-beta-D-;Hesperetin 7-rhamnoglucoside;Hesperetin 7-rutinoside;Hesperetin 7-[6-O- (6-deoxy-.alpha.-L-mannopyranosyl)]-.beta.-D-gluco pyranosid e);Hesperetin-7-rutinoside;(2S)-Hesperidin;S)-(-)-Hesperidine;Hesperidoside;Hesperitin-7-rhamnoglucoside;NSC44184;Usaf cf-3;5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxyhexopyranosyl)hexopyranoside;(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside;(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-beta-L-mannopyranosyl)-beta-D-glucopyranoside;(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(6-deoxy-alpha-L-erythro-hexopyranosyl)-beta-D-threo-hexopyranoside; | ||
Molecular Structure: |